Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Rosemarinus Officinalis Extract Pulpotomy

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting1
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07883239Not ApplicableCompleted

Bioceramic Repair Materials in Apexogenesis of Immature Permanent Molars

NCT07610057Not ApplicableNot Yet Recruiting

R. Officinalis as Pulpotomy Agent in Permanent Teeth With Irreversible Pulpitis

NCT06711081Not ApplicableRecruitingPrimary

Clinical & Radiographic Efficacy Using LLLT & CRYO on M.P.M Pulpotomy

Showing all 3 trials

Research Network

Common Treatments

  • Rosemarinus Officinalis Extract Pulpotomy1
  • Low Level Laser Device Cryotherapy1
  • Mta Pulpotomy1
  • Mineral Trioxide Aggregate Pulpotomy Biofactor Mta1
  • Bioceramic Repair Pulpotomy Bioc Repair1

Active Sponsors

  • Tanta University2
  • University of Health Sciences Lahore1

Top Investigators

Related Conditions

  • Cone Beam Computed Tomography1
  • Apexogenesis1
  • Pulpotomy1
  • Pulp Exposure Dental1
  • Irreversible Pulpitis1

Activity Timeline